Apotex launches Oviit a new range of vitamins and minerals

Apotex announced the launch of its new premium value, Pharmacy Only range of vitamin and mineral supplements (VMS), Oviit today (July 3, 2017). Expansion into this high growth VMS category signals further diversification of Apotex’s over-the-counter (OTC) portfolio, and a strategy for the generic drug manufacturer to restore value to the VMS category for pharmacy.…

Aussie biotech appoints American royalty to its Board of Directors

VIVA! Communications are thrilled to be working with Australian medical technology company Medibio as they today (June 4, 2017) announce the appointment of mental health advocate and former U.S. congressman, Patrick J.  Kennedy, to their Board of Directors. Patrick J. Kennedy is a former member of the U.S. House of Representatives and America’s leading political…

Government adds $142 million in medicines to PBS

As of July 1, 2017, the Federal Government has made AUD$142 million in new medicine listings to the Pharmaceutical Benefits Scheme (PBS), in a bid to make more medicines affordable to all Australians. Among the new listings, the PBS will fund access to vorinostat to treat patients living a subtype of blood cancer, non-Hodgkin’s lymphoma called…

Scientific breakthrough on objective diagnosis of PTSD

Findings from an Emory University, USA research study* released this week demonstrate a non-invasive protocol involving heart rate data and machine learning algorithms can accurately diagnose post-traumatic stress disorder (PTSD). The Classification of post-traumatic stress disorder from heart rate variability metrics with heart rate-based window segmentation study, involving technology developed by Emory University and licensed…

PROFILE: Annarosa tells us about living with osteoporosis

In September 2010, published author, wife and keen walker, Annarosa, 54, Sydney, was on an early Sunday morning walk in Balmain, when she tripped over her bootlaces and landed heavily on her wrist.  Soon after, she visited hospital emergency, where she underwent an X-ray that confirmed a fractured wrist. A few days later, Annarosa returned…

Failure to prevent fractures costing Australia billions each year

The brittle bones of Australians aged 50+ are expected to cost $3.1 billion in 2017, while the total cost over 10 years will climb to $21.9 billion by 2022. This is according to the first reports to analyse the cost and burden of poor bone health for all States and Territories nation-wide released by Osteoporosis…

Apotex launches vaccine ordering website

Apotex will launch an APOaccess online vaccine ordering portal today (Monday, June 26, 2017), offering pharmacy a one-stop solution to their vaccine ordering needs. The new portal follows the acquisition of Reform Management’s online vaccine ordering platform earlier this year, providing pharmacy with more than 50 vaccines, greater convenience and enhanced access nation-wide. The streamlined…

Promising vaccination that lowers cholesterol could prevent heart attacks

A promising new vaccination that is designed to prevent heart attacks is currently being developed by Austrian biotech company, AFFiRis. The research has shown that the injection can be targeted towards the immune system to lower cholesterol by stopping fatty deposits from clogging the arteries and reducing the risk of heart disease. The vaccine, known…

Queensland to bolster its biomedical industry with $4m injection

Addressing the BIO conference in San Diego on Monday, (June 19, 2017) QLD Premier, Annastacia Palaszczuk announced the launch of the Queensland Biomedical 10-Year Roadmap and Action Plan, which aims to bolster the QLD economy by upwards of AUD$2 billion by investing in biomedical sciences. A press release issued by the Premier’s office explains that…

Ground-breaking test developed in prostate cancer treatment

Scientists have this week announced an exciting new development in prostate cancer therapy with the news that a ground-breaking blood test can now monitor DNA to see if patients are responding to treatment. The test will enable doctors to check whether precision drugs are working and, if not, switch patients to a different treatment in…